1995
DOI: 10.1016/s0140-6736(95)90011-x
|View full text |Cite
|
Sign up to set email alerts
|

Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
97
0
4

Year Published

1996
1996
2022
2022

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 185 publications
(103 citation statements)
references
References 6 publications
2
97
0
4
Order By: Relevance
“…In support of the former is the observation that administration of FK-506 (tacrolimus), an immunosuppressant that binds to FKBP12.6, has been associated with the development of hypertrophic cardiomyopathy in children. 31,32 FKBP12.6 itself is known to bind to and modulate channel gating of the Ryr2 receptor. 33,34 Knockout mice lacking either FKBP12 or Ryr2 die during embryogenesis, 35,36 principally because of disruption of heart tube development.…”
Section: Discussionmentioning
confidence: 99%
“…In support of the former is the observation that administration of FK-506 (tacrolimus), an immunosuppressant that binds to FKBP12.6, has been associated with the development of hypertrophic cardiomyopathy in children. 31,32 FKBP12.6 itself is known to bind to and modulate channel gating of the Ryr2 receptor. 33,34 Knockout mice lacking either FKBP12 or Ryr2 die during embryogenesis, 35,36 principally because of disruption of heart tube development.…”
Section: Discussionmentioning
confidence: 99%
“…Binding of each of these drug-protein complexes to a catalytic subunit of carcineurin causes inhibition of signal transduction in T cell activation [3]. However, these agents have some adverse side-effects such as nephrotoxicity and chronic rejection [4,5]. Another potent immunosuppressive agent is desired to develop a safer medical treatment.…”
mentioning
confidence: 99%
“…Mice deficient in FKBP12 show severe heart defects associated with loss of function of cardiac ryanodine receptors (14). Similarly, treatment with high doses of FK506 can lead to severe heart failure (15).…”
mentioning
confidence: 99%